ArticleNature communications2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.
Lisa Brunet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it